Infection Surveillance Solutions Market to Reach US$ 763.7 Million at CAGR of 13.0% by 2025 | The Insight Partners

report image

Infection Surveillance Solutions Market to 2025 - Global Analysis and Forecasts By Type (Software and Services), End User (Hospitals, Nursing Homes, and Other End Users) and Geography

Publication Month: Feb 2019 | Report Code: TIPHE100001413 | No. of Pages: 183 | Category: Healthcare IT | Status: Published

The Infection Surveillance Solutions market was valued at US$ 294.1 million in 2017 and it is projected to reach US$ 763.7 million by 2025; it is expected to grow at a CAGR of 13.7% from 2018 to 2025.

Infection surveillance solutions refer to the software and integrated entities that helps to gather the medical data related to factors causing healthcare associated infections (HAIs) in the medical facilities and offer features in order to monitor, analyze, control as well as create a control action plan to reduce and prevent the HAIs. The growth of the Infection Surveillance Solutions market is attributed to the increasing number of healthcare associated infections, government initiatives for prevention of healthcare associated infections (HAIs), rise in the integration of information technology into various healthcare platforms are key drivers for the growth of the market. However, the growth of the market is restrained by various factors such as high costs of the software and dearth of skilled professionals to offer services in remote areas.

The Infection Surveillance Solutions market is expected to witness substantial growth post-pandemic. The Infection Surveillance Solutions market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Infection Surveillance Solutions Market



Lucrative Regions for Infection Surveillance Solutions in Healthcare Market

Get more information on this report :


Market Insights

Growing Applications of Infection Surveillance Solutions in Healthcare to Drive Infection Surveillance Solutions Market Growth

Healthcare associated infections, or nosocomial infections affects the patients in hospitals and other healthcare facilities that are not present in the patients at the time of admission. These infections affect the patients not only during their stay in the hospitals, but also post patient’s discharge from hospitals. Moreover, these occupational infections are observed to be common in within the hospital and nursing staff too. According to the World Health Organization (WHO), hundreds of millions of patients are affected by healthcare associated infections every year leading to significant morbidity and mortality around the world. The WHO Healthcare Associated Infections Fact Sheet of 2016 suggests that of every 100 hospitalized patients at a given time, 7 in the developed countries and 10 in developing countries acquires at least one healthcare associated infection.

Moreover, in high income countries, approximately 30% of patients in intensive care units (ICUs) are affected by at least one HAIs. This rate of HAIs is approximately 2-3 folds higher in the low and middle income countries. In addition, the WHO claims that the newborns are at a higher risk of developing these infections, with infection rates 3-20 times higher in developing countries as compared to high income countries of the globe. As a result of this significant prevalence rate of these infections, the endemic burden of health care associated infections is also turning up higher, majorly among the developing economies of the world. The European Centre for Disease Prevention and Control reports an average prevalence of 7.1% in European countries. The Centre estimates that 4 131 000 patients are affected by approximately 4 544 100 episodes of health care-associated infection every year in Europe. Thus, the increasing prevalence of HAIs is expected to create a demand for infection surveillance solutions promoting market growth across the world.

The healthcare associated infections acts as a major threat to patient safety, affecting one out of every 25 hospital patients at a given point, according to Agency for Healthcare Research & Quality. These infections are significantly increasing the economic burden of the healthcare system among all the countries worldwide. The government and healthcare departments of the high as well medium to low income countries are developing action plans and undertaking several initiatives to reduce this burden as well as prevent the mortality rates occurring as a result of hospital acquired infections or nosocomial infections. 

The prevention and reduction of healthcare-associated infections is a top priority for the U.S. Department of Health and Human Services (HHS). The HHS Steering Committee for the Prevention of Healthcare-Associated Infections was established in July 2008. The Steering Committee, along with scientists and program officials across HHS, developed the HHS Action Plan to prevent Healthcare-Associated Infections, providing a roadmap for HAI prevention in acute care hospitals. 

Moreover, the US Department of Health & Human Services have employed Agency for Healthcare Research and Quality that funds various works in the US to help the frontline clinicians and other healthcare staff to prevent HAIs by improving safety and care delivery to the patients. Not only in the North America and European high-income countries, major economies in Asia Pacific including Japan China and India are also significantly working to develop surveillance programs and promote the use of monitoring software for the prevention of these infections. For instance, Japan Healthcare System employed active surveillance, hand hygiene promotion, isolation cohort of resistant microorganism and bundle care for HAI prevention in various healthcare facilities. Additionally, the Australian Commission on Safety and Quality in Healthcare developed a Healthcare Associated Infection (HAI) Prevention Program aims to build on facility and jurisdictional initiatives to develop a national approach to reducing HAI by identifying and addressing systemic problems and gaps, and ensuring comprehensive actions are undertaken in a nationally coordinated way by leaders and decision makers in both public and private health care sectors. Thus, various government initiatives to reduce healthcare associated infections by adaption of advanced techniques such as surveillance software are expected to propel the growth of the global infection surveillance solutions market over the forecast yearsOver the years, technology has improved the way healthcare providers treat and take care of the patients. There have been a number of ways in which these changes in the healthcare systems are incorporated. The major one of these changes includes intersection of advanced healthcare and information technology. Health IT is often considered to be a silent partner in healthcare, which is not evidently noticed, however plays a crucial part of the system. The growing ageing population and rise in costly chronic care needs are exerting considerable demands on our health systems. Governments are expected to do more in the face of healthcare funding challenges and skilled labor shortage. As computer and technology use in hospitals, clinics and private practice expands, information technology is being used in countless ways to improve healthcare delivery, patient safety, and the relationship between patients and healthcare providers.

Surveillance of healthcare associated infections is of prime importance in prevention of infections. The methods and practices for surveillance have evolved as technology becomes more advanced. The availability of electronic surveillance software (ESS) has increased, and yet adoption of ESS is slow. The infection control software offers way to rebalance the time by monitoring several data feeds, alerting infection prevention, simplifying reporting, tracking trends graphically as well as improving outbreak identification. Due to the advantages offered by these software systems, government is investing significantly to promote the innovation in healthcare IT based systems. For instance, in 2017, the US health IT investment total whopped to US$ 7.1 billion. Thus, massive adoption of IT based platforms in healthcare is expected to support the growth of infection surveillance solutions market over the forecast years.

Type-Based Insights

In terms of type, the Infection Surveillance Solutions market is segmented into software and services. In 2017, the software segment held a largest market share of 62.5% of the infection surveillance solutions market, by technology.

Infection Surveillance Solutions Market, by Type – 2017 and 2025



Infection Surveillance Solutions in Healthcare Market, by Type – 2017 and 2025

Get more information on this report :


End User-Based Insights

In terms of end user, the Infection Surveillance Solutions market is segmented into hospitals, nursing homes, and other end users. The hospitals segment is anticipated to grow at a CAGR of 12.8% during the forecast period. The high prevalence of the hospital associated infection across the world is likely to enforce the healthcare setting for the adoption of these solutions in their infrastructure to prevent the healthcare associated infections.

Strategic Insights

Report Coverage - Infection Surveillance Solutions Market
Report CoverageDetails
Market Size Value inUS$ 294.1 Million in 2017
Market Size Value byUS$ 763.7 Million by 2025
Growth rateCAGR of 13.7% from 2018-2025
Forecast Period2018-2025
Base Year2018
No. of Pages183
Historical data availableYes
Segments coveredType , End User and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

The Infection Surveillance Solutions market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Infection Surveillance Solutions Market – by Type

  • Software

o Web-Based Software

o On-Premises Software

  • Services  

o Implementation Services

 o Support and Maintenance Services

  • o Training and Consulting Services

Infection Surveillance Solutions Market – by End User

  • Hospitals
  • Nursing Homes
  • Others

Infection Surveillance Solutions Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • BD
  • Wolters Kluwer
  • Sunquest Information Systems, Inc.
  • Premier
  • Baxter (ICNet Systems, Inc.)
  • GOJO Industries, Inc.
  • Cerner Corporation
  • Deb Group Ltd.
  • VigiLanz Corporation
  •  PeraHealth

The List Of Companies

  1. BD
  2. Wolters Kluwer
  3. Sunquest Information Systems, Inc.
  4. Premier
  5. Baxter
  6. GOJO Industries, Inc.
  7. Cerner Corporation
  8. Deb Group Ltd.
  9. PeraHealth
  10. VigiLanz Corporation
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the infection surveillance solutions market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infection surveillance solutions treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPHE100001413
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $3640
  • $6550 $5240
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount